Concurrent Investment Advisors’s Schwab US Dividend Equity ETF SCHD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Sell
348,107
-60,208
-15% -$1.83M 0.12% 191
2025
Q4
$11.2M Sell
408,315
-32,082
-7% -$872K 0.13% 167
2025
Q3
$12M Sell
440,397
-26,249
-6% -$716K 0.21% 102
2025
Q2
$12.4M Buy
466,646
+20,265
+5% +$529K 0.24% 90
2025
Q1
$12.5M Buy
446,381
+259,146
+138% +$7.22M 0.3% 69
2024
Q4
$5.12M Buy
187,235
+34,493
+23% +$981K 0.14% 156
2024
Q3
$4.3M Buy
152,742
+81,420
+114% +$2.22M 0.13% 171
2024
Q2
$1.85M Buy
71,322
+14,307
+25% +$372K 0.06% 293
2024
Q1
$1.53M Buy
57,015
+43,842
+333% +$1.13M 0.06% 289
2023
Q4
$334K Buy
+13,173
New +$314K 0.02% 618

Other funds holding SCHD

Concurrent Investment Advisors's SCHD Position: Q1 2026 in Review

Concurrent Investment Advisors reduced its Schwab US Dividend Equity ETF (SCHD) stake by 15% in Q1 2026, selling an estimated $1.83M and leaving 348,107 shares worth $10.7M. The position accounts for 0.12% of the portfolio, ranked #191.

Concurrent Investment Advisors first reported a position in SCHD in Q4 2023 and has held it in 10 quarters since. The position peaked at $12.5M in Q1 2025. 2,044 funds tracked by Wall St. Rank hold SCHD as of Q1 2026.

  • Concurrent Investment Advisors held 348,107 shares of Schwab US Dividend Equity ETF worth $10.7M as of Q1 2026.
  • Concurrent Investment Advisors sold 60,208 Schwab US Dividend Equity ETF shares in Q1 2026, an estimated $1.83M.
  • Schwab US Dividend Equity ETF made up 0.12% of Concurrent Investment Advisors's portfolio in Q1 2026, its #191 holding.
  • Concurrent Investment Advisors first reported a position in Schwab US Dividend Equity ETF in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's Schwab US Dividend Equity ETF position peaked at $12.5M in Q1 2025.
  • 2,044 funds tracked by Wall St. Rank held Schwab US Dividend Equity ETF as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.